Literature DB >> 33116783

Blood Pressure Control, Left Ventricular Hypertrophy and Treatment Practice Among Hypertensive Patients in Ethiopia.

Daniel Gebrehawaria Kinfe1, Gebretsadik Berhe2, Kibreab Gidey3, Gebre Teklemariam Demoz4.   

Abstract

BACKGROUND: Globally, hypertension is the most important public health issue and is a increasing health problem in Ethiopia. Blood pressure (BP) control is an ultimate therapeutic goal of hypertensive patients in reducing early complications of hypertension. Hence, this study was sought to examine the magnitude of uncontrolled BP, left ventricular hypertrophy (LVH), and treatment practice. Predictors of uncontrolled BP and LVH were also investigated.
METHODS: A hospital-based cross-sectional study was conducted among 223 outpatients with hypertension on follow-up at Ayder Comprehensive Specialized Hospital (ACSH). Hypertensive patients with ≥18 years old who had been on follow-up care for at least 3 months were included in the study. Severely ill patients requiring urgent medical care and wheelchair-bound individuals or persons who had difficulty standing steady and pregnant women were excluded. Data were collected using a structured questionnaire and patients' chart review. Data were entered and analyzed using SPSS version 22.0. To identify predictors, binary logistic regression model analysis was performed. Statistical significance was set at P-value of < 0.05.
RESULTS: The magnitude of uncontrolled BP (>140/90mmgH) and LVH was found to be 31.4% and 39.5%, respectively. More than half (53%) of participants were on at least two antihypertensive drug combinations of different classes. Uncontrolled BP was significantly associated with poor adherence to salt reduction in meal (Adjusted Odds Ratio (AOR) =8.552, 95% CI: 2.853, 15.638, P<0.001), non-adherence to medications (AOR =2.886, 95% CI: 1.710, 3.935, P<0.001), and taking triple-drug therapy (AOR=7.228, 95% CI: 1.110, 10.57, P=0.039). Presence of LVH was significantly associated with abdominal obesity (AOR= 2.2, 95% CI: 1.399, 4.69, P=0.003), age of ≥60 years (AOR= 2.421, 95% CI: 1.263, 4.639, P=0.008), and uncontrolled BP (AOR= 3.16, 95% CI: 1.208, 5.232, P=0.021).
CONCLUSION: In this study, a significant proportion of patients with uncontrolled BP and LVH were found. Abdominal obesity, older age and uncontrolled blood pressure were predictors of LVH. Therefore, tailored interventions targeting BP control to reduce the magnitude of LVH and other early complications of hypertension deemed to be compulsory.
© 2020 Kinfe et al.

Entities:  

Keywords:  Ethiopia; blood pressure; hypertension; left ventricular hypertrophy; predictors

Year:  2020        PMID: 33116783      PMCID: PMC7585827          DOI: 10.2147/IJGM.S273668

Source DB:  PubMed          Journal:  Int J Gen Med        ISSN: 1178-7074


  29 in total

Review 1.  Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health.

Authors: 
Journal:  Obes Res       Date:  1998-09

2.  Effects of alcohol reduction on blood pressure: a meta-analysis of randomized controlled trials.

Authors:  X Xin; J He; M G Frontini; L G Ogden; O I Motsamai; P K Whelton
Journal:  Hypertension       Date:  2001-11       Impact factor: 10.190

3.  Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension.

Authors:  J He; P K Whelton; L J Appel; J Charleston; M J Klag
Journal:  Hypertension       Date:  2000-02       Impact factor: 10.190

4.  Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group.

Authors:  P K Whelton; L J Appel; M A Espeland; W B Applegate; W H Ettinger; J B Kostis; S Kumanyika; C R Lacy; K C Johnson; S Folmar; J A Cutler
Journal:  JAMA       Date:  1998-03-18       Impact factor: 56.272

5.  Trends in antihypertensive medication use and blood pressure control among United States adults with hypertension: the National Health And Nutrition Examination Survey, 2001 to 2010.

Authors:  Qiuping Gu; Vicki L Burt; Charles F Dillon; Sarah Yoon
Journal:  Circulation       Date:  2012-10-23       Impact factor: 29.690

6.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

7.  Assessment of Blood Pressure Control among Hypertensive Patients in Southwest Ethiopia.

Authors:  Solomon Woldegebriel Asgedom; Esayas Kebede Gudina; Tigestu Alemu Desse
Journal:  PLoS One       Date:  2016-11-23       Impact factor: 3.240

8.  Uncontrolled hypertension and associated factors among adult hypertensive patients in Ayder comprehensive specialized hospital, Tigray, Ethiopia, 2018.

Authors:  Gebrewahd Bezabh Gebremichael; Kalayou Kidanu Berhe; Teklewoini Mariye Zemichael
Journal:  BMC Cardiovasc Disord       Date:  2019-05-22       Impact factor: 2.298

9.  Clinical practice guidelines for the management of hypertension in the community: a statement by the American Society of Hypertension and the International Society of Hypertension.

Authors:  Michael A Weber; Ernesto L Schiffrin; William B White; Samuel Mann; Lars H Lindholm; John G Kenerson; John M Flack; Barry L Carter; Barry J Materson; C Venkata S Ram; Debbie L Cohen; Jean-Claude Cadet; Roger R Jean-Charles; Sandra Taler; David Kountz; Raymond R Townsend; John Chalmers; Agustin J Ramirez; George L Bakris; Jiguang Wang; Aletta E Schutte; John D Bisognano; Rhian M Touyz; Dominic Sica; Stephen B Harrap
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-12-17       Impact factor: 3.738

10.  Pattern of blood pressure distribution and prevalence of hypertension and prehypertension among adults in Northern Ethiopia: disclosing the hidden burden.

Authors:  Mekoya D Mengistu
Journal:  BMC Cardiovasc Disord       Date:  2014-03-05       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.